Search - tctmd.com

Displaying 181 - 200 of 357

Sort: Relevancy | Date

News Conference News TCT 2017

Long-term Absorb BVS Data Continue to Disappoint

Michael O'Riordan

October 31, 2017

Presentation TCT 2017

ABSORB IV: 30-Day Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Gregg W. Stone

October 31, 2017

News Conference News TCT 2017

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

Michael O'Riordan

October 30, 2017

Presentation TCT 2017

Topic 4: At the Cusp of Diminishing Returns for CV Therapies - Personalized Approaches and New Frontiers

Presenter: Robert A. Byrne, Gregg W. Stone, Robert A. Harrington

October 30, 2017

Presentation TCT 2017

Topic 3: Chronic Total Occlusion PCI - What Level of Evidence Is Required for Widespread Acceptance: Hard Endpoints vs QOL Measures

Presenter: Robert A. Byrne, Gregg W. Stone, J. Aaron Grantham

October 30, 2017

Presentation TCT 2017

Topic 2: Outcomes Without a Clear Mechanism (Radial Mortality Benefit, Aspirin/Ticagrelor Interaction, and More)

Presenter: Robert A. Byrne, Gregg W. Stone, Robert A. Harrington

October 30, 2017

Presentation TCT 2017

Topic 1: How Should We Evaluate Technologies in Their Infancy? TAVR, Renal Denervation, BVS, LAA Closure, Mechanical Circulatory Support, and More

Presenter: Robert A. Byrne, Gregg W. Stone, Aaron V. Kaplan

October 30, 2017

Presentation TCT 2017

DKCRUSH-V: A Randomized Trial of Double Kissing Crush vs Provisional Stenting for Treatment of Distal Left Main Bifurcation Lesions

Presenter: Gregg W. Stone, Shao-Liang Chen

October 30, 2017

News Conference News TCT 2017

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

Yael L. Maxwell

October 30, 2017

Presentation TCT 2017

EXCEL QOL: Quality of Life After PCI vs CABG in Left Main Coronary Artery Disease

Presenter: Gregg W. Stone, Suzanne J. Baron

October 30, 2017

Presentation TCT 2017

CULPRIT-SHOCK: A Randomized Trial of Multivessel PCI in Cardiogenic Shock

Presenter: Gregg W. Stone, Holger Thiele

October 30, 2017

Presentation TCT 2017

The Essential Technical Approach to Left Main Bifurcation Lesions

Presenter: Gregg W. Stone, Bo Xu, Kefei Dou

October 29, 2017

Presentation TCT 2017

Case Presentation: Left Main Bifurcation (Medina 1,1,1)

Presenter: Gregg W. Stone, Bo Xu, Zening Jin

October 29, 2017

Presentation TCT 2017

Current Practice and Perspectives on Treatment of Left Main Bifurcation in China

Presenter: Gregg W. Stone, Bo Xu, Shao-Liang Chen

October 29, 2017

Presentation TCT 2017

Indication and Evidence for Left Main Bifurcation PCI

Presenter: Gregg W. Stone, Bo Xu, Ajay J. Kirtane

October 29, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Daily News

Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond

Michael O'Riordan

October 17, 2017

News Daily News

Bleeding and Ischemic Events Fluctuate Out to 1 Year Post-STEMI: HORIZONS-AMI

Yael L. Maxwell

October 03, 2017

News Features

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

Michael O'Riordan

September 13, 2017

News Conference News ESC 2017

Supplemental Oxygen Provides No Benefit to Patients With Suspected MI: DETO2X-AMI

Michael O'Riordan

August 28, 2017

Advertisement

Long-term Absorb BVS Data Continue to Disappoint

ABSORB IV: 30-Day Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

Topic 4: At the Cusp of Diminishing Returns for CV Therapies - Personalized Approaches and New Frontiers

Topic 3: Chronic Total Occlusion PCI - What Level of Evidence Is Required for Widespread Acceptance: Hard Endpoints vs QOL Measures

Topic 2: Outcomes Without a Clear Mechanism (Radial Mortality Benefit, Aspirin/Ticagrelor Interaction, and More)

Topic 1: How Should We Evaluate Technologies in Their Infancy? TAVR, Renal Denervation, BVS, LAA Closure, Mechanical Circulatory Support, and More

DKCRUSH-V: A Randomized Trial of Double Kissing Crush vs Provisional Stenting for Treatment of Distal Left Main Bifurcation Lesions

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

EXCEL QOL: Quality of Life After PCI vs CABG in Left Main Coronary Artery Disease

CULPRIT-SHOCK: A Randomized Trial of Multivessel PCI in Cardiogenic Shock

The Essential Technical Approach to Left Main Bifurcation Lesions

Case Presentation: Left Main Bifurcation (Medina 1,1,1)

Current Practice and Perspectives on Treatment of Left Main Bifurcation in China

Indication and Evidence for Left Main Bifurcation PCI

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond

Bleeding and Ischemic Events Fluctuate Out to 1 Year Post-STEMI: HORIZONS-AMI

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

Supplemental Oxygen Provides No Benefit to Patients With Suspected MI: DETO2X-AMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content